60 related articles for article (PubMed ID: 23656247)
1. Influence of different cell storage/culture conditions on spontaneous proliferation and level of tyrosine kinase receptor inhibition in two feline injection-site sarcoma cell lines.
Feldhaeusser BR; Turek M; Lawrence J; Cornell K; Gogal RM
J Immunoassay Immunochem; 2013; 34(3):266-82. PubMed ID: 23656247
[TBL] [Abstract][Full Text] [Related]
2. Masitinib mesylate does not enhance sensitivity to radiation in three feline injection-site sarcoma cell lines under normal growth conditions.
Turek M; Gogal R; Saba C; Vandenplas ML; Hill J; Feldhausser B; Lawrence J
Res Vet Sci; 2014 Apr; 96(2):304-7. PubMed ID: 24602916
[TBL] [Abstract][Full Text] [Related]
3. Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells.
Lawrence J; Saba C; Gogal R; Lamberth O; Vandenplas ML; Hurley DJ; Dubreuil P; Hermine O; Dobbin K; Turek M
Vet Comp Oncol; 2012 Jun; 10(2):143-54. PubMed ID: 22236016
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells.
Fahey CE; Milner RJ; Kow K; Bacon NJ; Salute ME
Anticancer Drugs; 2013 Jun; 24(5):519-26. PubMed ID: 23466652
[TBL] [Abstract][Full Text] [Related]
5. Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival.
Shor AC; Keschman EA; Lee FY; Muro-Cacho C; Letson GD; Trent JC; Pledger WJ; Jove R
Cancer Res; 2007 Mar; 67(6):2800-8. PubMed ID: 17363602
[TBL] [Abstract][Full Text] [Related]
6. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia.
Inge LJ; Fowler AJ; Paquette KM; Richer AL; Tran N; Bremner RM
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):531-8. PubMed ID: 23142123
[TBL] [Abstract][Full Text] [Related]
7. In vitro antiproliferative and antimigratory activity of dasatinib in neuroblastoma and Ewing sarcoma cell lines.
Timeus F; Crescenzio N; Fandi A; Doria A; Foglia L; Cordero di Montezemolo L
Oncol Rep; 2008 Feb; 19(2):353-9. PubMed ID: 18202781
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
Kubo T; Shimose S; Matsuo T; Tanaka K; Yasunaga Y; Sakai A; Ochi M
J Orthop Res; 2006 Jun; 24(6):1138-44. PubMed ID: 16705696
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative effect of metformin on a feline injection site sarcoma cell line independent of Mtor inhibition.
Pierro J; Saba C; McLean K; Williams R; Karpuzoglu E; Prater R; Hoover K; Gogal R
Res Vet Sci; 2017 Oct; 114():74-79. PubMed ID: 28319830
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivo.
Hingorani P; Zhang W; Gorlick R; Kolb EA
Clin Cancer Res; 2009 May; 15(10):3416-22. PubMed ID: 19447875
[TBL] [Abstract][Full Text] [Related]
11. In vitro efficacy of doxorubicin and etoposide against a feline injection site sarcoma cell line.
Hill J; Lawrence J; Saba C; Turek M; Feldhaeusser B; Coutermarsh-Ott S; Barber J; Smith J; Gogal R
Res Vet Sci; 2014 Oct; 97(2):348-56. PubMed ID: 25085537
[TBL] [Abstract][Full Text] [Related]
12. Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c.
Lu X; Hsieh TC; Wu JM
Int J Oncol; 2004 Dec; 25(6):1801-7. PubMed ID: 15547720
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib.
Wang L; Guo B; Wang R; Jiang Y; Qin S; Liang S; Zhao Y; Guo W; Li K; Fan X
Clin Sci (Lond); 2012 Jan; 122(1):13-24. PubMed ID: 21751967
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen.
Dhiman HK; Ray AR; Panda AK
Biomaterials; 2005 Mar; 26(9):979-86. PubMed ID: 15369686
[TBL] [Abstract][Full Text] [Related]
15. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell lines.
Lyles SE; Milner RJ; Kow K; Salute ME
Vet Comp Oncol; 2012 Sep; 10(3):223-35. PubMed ID: 22594682
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids.
Brodowicz T; Wiltschke C; Kandioler-Eckersberger D; Grunt TW; Rudas M; Schneider SM; Hejna M; Budinsky A; Zielinski CC
Br J Cancer; 1999 Jul; 80(9):1350-8. PubMed ID: 10424735
[TBL] [Abstract][Full Text] [Related]
18. Effects of ibuprofen on the viability and proliferation of rainbow trout liver cell lines and potential problems and interactions in effects assessment.
Schnell S; Kawano A; Porte C; Lee LE; Bols NC
Environ Toxicol; 2009 Apr; 24(2):157-65. PubMed ID: 18563801
[TBL] [Abstract][Full Text] [Related]
19. Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines.
Roomi MW; Kalinovsky T; Roomi NW; Rath M; Niedzwiecki A
Oncol Rep; 2012 Jan; 27(1):17-27. PubMed ID: 21947138
[TBL] [Abstract][Full Text] [Related]
20. AEE788 is a vascular endothelial growth factor receptor tyrosine kinase inhibitor with antiproliferative and proapoptotic effects in acute myeloid leukemia.
Barbarroja N; Torres LA; Rodriguez-Ariza A; Valverde-Estepa A; Lopez-Sanchez LM; Ruiz-Limon P; Perez-Sanchez C; Carretero RM; Velasco F; López-Pedrera C
Exp Hematol; 2010 Aug; 38(8):641-52. PubMed ID: 20380868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
